Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.495
-0.145 (-8.84%)
Aug 14, 2025, 2:07 PM - Market open
Canopy Growth Market Cap
Canopy Growth has a market cap or net worth of $395.46 million as of August 14, 2025. Its market cap has decreased by -29.48% in one year.
Market Cap
395.46M
Enterprise Value
529.06M
1-Year Change
-29.48%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $395.46M, a decrease of -93.02%. That is a compound annual growth rate of -30.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 393.40M | 36.27% |
| Dec 31, 2024 | 288.70M | -31.86% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |